PubMed · The Lancet Infectious Diseases· Bakary Fofana·· 2 天前
Ganaplacide联合lumefantrine固体分散体治疗儿童非复杂性恶性疟的KALUMI开放标签多中心随机对照II期非劣效试验
Ganaplacide plus lumefantrine solid dispersion formulation for children with uncomplicated Plasmodium falciparum malaria (KALUMI): an open-label, multicentre, randomised, controlled, adaptive, phase 2, non-inferiority trial.
AI 导读
一项在布基纳法索、马里、科特迪瓦、加蓬和刚果（金）十家机构开展的开放标签、多中心、随机、适应性、II期非劣效试验（NCT04546633，已完成），评估ganaplacide 400 mg联合lumefantrine固体分散体治疗非复杂性恶性疟儿童（6个月至<18岁）的食物效应与非劣效性，对照artemether-lumefantrine。
来源：PubMed · The Lancet Infectious Diseases · pubmed.ncbi.nlm.nih.gov